Chemoinformaics analysis of Trans-Cinnamyl acetate
Molecular Weight | 176.215 | nRot | 3 |
Heavy Atom Molecular Weight | 164.119 | nRig | 8 |
Exact Molecular Weight | 176.084 | nRing | 1 |
Solubility: LogS | -2.203 | nHRing | 0 |
Solubility: LogP | 2.151 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 27.9755 |
nHD | 0 | BPOL | 14.6425 |
QED | 0.66 |
Synth | 1.855 |
Natural Product Likeliness | 0.867 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.006 |
Pgp-sub | 0.006 |
HIA | 0.008 |
CACO-2 | -4.515 |
MDCK | 0.0000303 |
BBB | 0.989 |
PPB | 0.732717 |
VDSS | 0.849 |
FU | 0.275937 |
CYP1A2-inh | 0.988 |
CYP1A2-sub | 0.163 |
CYP2c19-inh | 0.609 |
CYP2c19-sub | 0.361 |
CYP2c9-inh | 0.113 |
CYP2c9-sub | 0.674 |
CYP2d6-inh | 0.094 |
CYP2d6-sub | 0.493 |
CYP3a4-inh | 0.059 |
CYP3a4-sub | 0.32 |
CL | 6.528 |
T12 | 0.838 |
hERG | 0.039 |
Ames | 0.417 |
ROA | 0.032 |
SkinSen | 0.916 |
Carcinogencity | 0.702 |
EI | 0.988 |
Respiratory | 0.05 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.718407 |